![Cancers | Free Full-Text | Single-Cell Transcriptomic Analysis of Tumor-Derived Fibroblasts and Normal Tissue-Resident Fibroblasts Reveals Fibroblast Heterogeneity in Breast Cancer Cancers | Free Full-Text | Single-Cell Transcriptomic Analysis of Tumor-Derived Fibroblasts and Normal Tissue-Resident Fibroblasts Reveals Fibroblast Heterogeneity in Breast Cancer](https://pub.mdpi-res.com/cancers/cancers-12-01307/article_deploy/html/images/cancers-12-01307-g006.png?1591375441)
Cancers | Free Full-Text | Single-Cell Transcriptomic Analysis of Tumor-Derived Fibroblasts and Normal Tissue-Resident Fibroblasts Reveals Fibroblast Heterogeneity in Breast Cancer
![Immunofluorescence analysis of fibroblast-specific protein 1 (FSP1) and... | Download Scientific Diagram Immunofluorescence analysis of fibroblast-specific protein 1 (FSP1) and... | Download Scientific Diagram](https://www.researchgate.net/publication/277999209/figure/fig3/AS:294350648037377@1447190071170/Immunofluorescence-analysis-of-fibroblast-specific-protein-1-FSP1-and-the-mesenchymal.png)
Immunofluorescence analysis of fibroblast-specific protein 1 (FSP1) and... | Download Scientific Diagram
![Direct conversion of injury-site myeloid cells to fibroblast-like cells of granulation tissue | Nature Communications Direct conversion of injury-site myeloid cells to fibroblast-like cells of granulation tissue | Nature Communications](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41467-018-03208-w/MediaObjects/41467_2018_3208_Fig1_HTML.jpg)
Direct conversion of injury-site myeloid cells to fibroblast-like cells of granulation tissue | Nature Communications
![Role and mechanism of CD90+ fibroblasts in inflammatory diseases and malignant tumors | Molecular Medicine | Full Text Role and mechanism of CD90+ fibroblasts in inflammatory diseases and malignant tumors | Molecular Medicine | Full Text](https://media.springernature.com/m685/springer-static/image/art%3A10.1186%2Fs10020-023-00616-7/MediaObjects/10020_2023_616_Fig3_HTML.png)
Role and mechanism of CD90+ fibroblasts in inflammatory diseases and malignant tumors | Molecular Medicine | Full Text
![Fibroblast heterogeneity and the role of CD90 (Thy-1) in skin fibrosis in scleroderma - Research Projects - Korman Lab - Rochester, NY - University of Rochester Medical Center Fibroblast heterogeneity and the role of CD90 (Thy-1) in skin fibrosis in scleroderma - Research Projects - Korman Lab - Rochester, NY - University of Rochester Medical Center](https://www.urmc.rochester.edu/MediaLibraries/URMCMedia/labs/korman-lab/images/4CD90-fibrosis.jpg)
Fibroblast heterogeneity and the role of CD90 (Thy-1) in skin fibrosis in scleroderma - Research Projects - Korman Lab - Rochester, NY - University of Rochester Medical Center
![Difference of marker expression between NEFs and CAFs. Fibroblasts were... | Download Scientific Diagram Difference of marker expression between NEFs and CAFs. Fibroblasts were... | Download Scientific Diagram](https://www.researchgate.net/publication/305677686/figure/fig1/AS:415483934330880@1476070497377/Difference-of-marker-expression-between-NEFs-and-CAFs-Fibroblasts-were-collected-from.png)
Difference of marker expression between NEFs and CAFs. Fibroblasts were... | Download Scientific Diagram
![Altered Dermal Fibroblasts in Systemic Sclerosis Display Podoplanin and CD90. - Abstract - Europe PMC Altered Dermal Fibroblasts in Systemic Sclerosis Display Podoplanin and CD90. - Abstract - Europe PMC](https://europepmc.org/articles/PMC5222985/bin/gr2.jpg)
Altered Dermal Fibroblasts in Systemic Sclerosis Display Podoplanin and CD90. - Abstract - Europe PMC
![Altered Dermal Fibroblasts in Systemic Sclerosis Display Podoplanin and CD90. - Abstract - Europe PMC Altered Dermal Fibroblasts in Systemic Sclerosis Display Podoplanin and CD90. - Abstract - Europe PMC](https://europepmc.org/articles/PMC5222985/bin/gr3.jpg)
Altered Dermal Fibroblasts in Systemic Sclerosis Display Podoplanin and CD90. - Abstract - Europe PMC
![Anti-Fibroblasts Marker (CD90, Thy-1) Antibody (Clone: AS02) DIA-100 from dianova GmbH | Biocompare.com Anti-Fibroblasts Marker (CD90, Thy-1) Antibody (Clone: AS02) DIA-100 from dianova GmbH | Biocompare.com](https://media.biocompare.com/m/37/images/anti-fibroblasts-marker-cd90-thy-1-antibody-clone-as02-3562233-400x300.jpg)
Anti-Fibroblasts Marker (CD90, Thy-1) Antibody (Clone: AS02) DIA-100 from dianova GmbH | Biocompare.com
![The influence of CD26+ and CD26− fibroblasts on the regeneration of human dermo-epidermal skin substitutes | Scientific Reports The influence of CD26+ and CD26− fibroblasts on the regeneration of human dermo-epidermal skin substitutes | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-022-05309-5/MediaObjects/41598_2022_5309_Fig1_HTML.jpg)
The influence of CD26+ and CD26− fibroblasts on the regeneration of human dermo-epidermal skin substitutes | Scientific Reports
![Role and mechanism of CD90+ fibroblasts in inflammatory diseases and malignant tumors | Molecular Medicine | Full Text Role and mechanism of CD90+ fibroblasts in inflammatory diseases and malignant tumors | Molecular Medicine | Full Text](https://media.springernature.com/m685/springer-static/image/art%3A10.1186%2Fs10020-023-00616-7/MediaObjects/10020_2023_616_Fig2_HTML.png)
Role and mechanism of CD90+ fibroblasts in inflammatory diseases and malignant tumors | Molecular Medicine | Full Text
![A) Flow cytometry analysis of fibroblast specific surface marker CD 90... | Download Scientific Diagram A) Flow cytometry analysis of fibroblast specific surface marker CD 90... | Download Scientific Diagram](https://www.researchgate.net/publication/322841475/figure/fig1/AS:818887121727488@1572249312471/A-Flow-cytometry-analysis-of-fibroblast-specific-surface-marker-CD-90-and-MSCs-specific.png)
A) Flow cytometry analysis of fibroblast specific surface marker CD 90... | Download Scientific Diagram
![Loss of Fas-signaling in pro-fibrotic fibroblasts impairs homeostatic fibrosis resolution and promotes persistent pulmonary fibrosis | bioRxiv Loss of Fas-signaling in pro-fibrotic fibroblasts impairs homeostatic fibrosis resolution and promotes persistent pulmonary fibrosis | bioRxiv](https://www.biorxiv.org/content/biorxiv/early/2020/08/19/2020.08.18.255869/F5.large.jpg)
Loss of Fas-signaling in pro-fibrotic fibroblasts impairs homeostatic fibrosis resolution and promotes persistent pulmonary fibrosis | bioRxiv
![Frontiers | CD49b, CD87, and CD95 Are Markers for Activated Cancer-Associated Fibroblasts Whereas CD39 Marks Quiescent Normal Fibroblasts in Murine Tumor Models Frontiers | CD49b, CD87, and CD95 Are Markers for Activated Cancer-Associated Fibroblasts Whereas CD39 Marks Quiescent Normal Fibroblasts in Murine Tumor Models](https://www.frontiersin.org/files/Articles/468769/fonc-09-00716-HTML-r1/image_m/fonc-09-00716-g001.jpg)
Frontiers | CD49b, CD87, and CD95 Are Markers for Activated Cancer-Associated Fibroblasts Whereas CD39 Marks Quiescent Normal Fibroblasts in Murine Tumor Models
![CD105+CD90+CD13+ identifies a clonogenic subset of adventitial lung fibroblasts | Scientific Reports CD105+CD90+CD13+ identifies a clonogenic subset of adventitial lung fibroblasts | Scientific Reports](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41598-021-03963-9/MediaObjects/41598_2021_3963_Fig2_HTML.png)
CD105+CD90+CD13+ identifies a clonogenic subset of adventitial lung fibroblasts | Scientific Reports
![Frontiers | Targeting Dermal Fibroblast Subtypes in Antifibrotic Therapy: Surface Marker as a Cellular Identity or a Functional Entity? Frontiers | Targeting Dermal Fibroblast Subtypes in Antifibrotic Therapy: Surface Marker as a Cellular Identity or a Functional Entity?](https://www.frontiersin.org/files/Articles/694605/fphys-12-694605-HTML/image_m/fphys-12-694605-g001.jpg)
Frontiers | Targeting Dermal Fibroblast Subtypes in Antifibrotic Therapy: Surface Marker as a Cellular Identity or a Functional Entity?
![Role and mechanism of CD90+ fibroblasts in inflammatory diseases and malignant tumors | Molecular Medicine | Full Text Role and mechanism of CD90+ fibroblasts in inflammatory diseases and malignant tumors | Molecular Medicine | Full Text](https://media.springernature.com/m685/springer-static/image/art%3A10.1186%2Fs10020-023-00616-7/MediaObjects/10020_2023_616_Fig1_HTML.png)